Robbins Umeda LLP Announces an Investigation of the Acquisition of Eclipsys Corp. by Allscripts-Misys Healthcare Solutions, Inc.

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of Eclipsys Corporation ("Eclipsys" or the "Company") (NASDAQ: ECLP) in connection with their actions in causing Eclipsys to enter into a definitive merger agreement to be acquired by Allscripts-Misys Healthcare Solutions, Inc. ("Allscripts") (NASDAQ: MDRX). If the transaction is completed, Eclipsys shareholders will receive 1.2 shares of Allscripts stock for each share of Eclipsys they hold. If approved, the transaction is expected to be completed in the next four to six months.

Robbins Umeda LLP's investigation concerns whether the Board of Directors of Eclipsys undertook a fair process to obtain fair consideration for all shareholders of Eclipsys. The Company stated that its diluted earnings per share for the first quarter of 2010 were $0.19, easily beating several analyst estimates. Additionally, the Company was recently upgraded to "Outperform" by at least one analyst.

If you are a shareholder of Eclipsys and would like more information about your rights as a shareholder, please contact attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at inquiry@robbinsumeda.com.

Robbins Umeda LLP is a California-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please go to http://www.robbinsumeda.com.

Eclipsys Corp. (MM) (NASDAQ:ECLP)
過去株価チャート
から 11 2024 まで 12 2024